Barbara Yanni - 12 May 2022 Form 4 Insider Report for VACCINEX, INC. (VCNX)

Role
Director
Signature
/s/ Scott E. Royer, Attorney-in-Fact for Barbara Yanni
Issuer symbol
VCNX
Transactions as of
12 May 2022
Net transactions value
$0
Form type
4
Filing time
13 May 2022, 16:39:46 UTC
Previous filing
29 Jul 2021
Next filing
13 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VCNX Stock Option (Right to Buy) Award $0 +53,254 $0.000000 53,254 12 May 2022 Common Stock 53,254 $1.12 Direct F5
holding VCNX Stock Option (Right to Buy) 6,396 12 May 2022 Common Stock 6,396 $13.60 Direct F1
holding VCNX Stock Option (Right to Buy) 7,718 12 May 2022 Common Stock 7,718 $7.78 Direct F2
holding VCNX Stock Option (Right to Buy) 15,679 12 May 2022 Common Stock 15,679 $3.95 Direct F3
holding VCNX Stock Option (Right to Buy) 28,586 12 May 2022 Common Stock 28,586 $2.15 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exercisable in full as of the date of this report.
F2 This option expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first.
F3 This option expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first.
F4 This option expires on May 9, 2031 or five years following retirement or cessation of services, whichever occurs first.
F5 This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 9, 2032 or five years following retirement or cessation of services, whichever occurs first.